HUTCHMED (China) (HCM) Assets Average (2016 - 2025)
HUTCHMED (China)'s (HCM) quarterly Assets Average came in at $1.0 billion in Q4 2025, up 40.47% year-on-year from $712.4 million in Q4 2024, and up 3.17% on a QoQ basis from $969.9 million in Q2 2025.
HUTCHMED (China) (HCM) Assets Average (2016 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 9 years of Assets Average data on file, last reported at $1.0 billion in Q4 2025.
- On a quarterly basis, Assets Average rose 40.47% year-over-year to $1.0 billion in Q4 2025; TTM through Dec 2025 was $1.0 billion, a 40.47% increase from a year earlier, with the FY2025 full-year figure at $194.4 million, up 137.79% from the prior year.
- Assets Average for Q4 2025 stood at $1.0 billion, up from $969.9 million in the prior quarter.
- Over the last five years, Assets Average for HCM reached as high as $1.0 billion in Q4 2025 and fell as low as $630.5 million in Q2 2024.
- Historically, Assets Average has averaged $781.6 million across 5 years, with a median of $714.5 million in 2023.
- Across the five-year window, Assets Average surged 109.81% in 2021 and slumped 30.29% in 2022, its largest moves.
- Year by year, Assets Average stood at $724.6 million in 2021, then retreated by 8.5% to $663.0 million in 2022, then retreated by 2.13% to $648.8 million in 2023, then climbed by 9.8% to $712.4 million in 2024, then soared by 40.47% to $1.0 billion in 2025.
- Per Business Quant data, the three most recent Assets Average figures were $1.0 billion in Q4 2025, $969.9 million in Q2 2025, and $712.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 1.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Bn |
| Jun 30, 2025 | 969.92 Mn |
| Dec 31, 2024 | 712.38 Mn |
| Jun 30, 2024 | 630.52 Mn |
| Dec 31, 2023 | 648.83 Mn |
| Jun 30, 2023 | 714.55 Mn |
| Dec 31, 2022 | 662.97 Mn |
| Jun 30, 2022 | 685.28 Mn |
| Dec 31, 2021 | 724.55 Mn |
| Jun 30, 2021 | 983.00 Mn |
| Mar 31, 2021 | 864.67 Mn |
| Dec 31, 2020 | 780.89 Mn |
| Jun 30, 2020 | 468.84 Mn |
| Mar 31, 2020 | 412.12 Mn |
| Dec 31, 2019 | 433.11 Mn |
| Sep 30, 2019 | 474.65 Mn |
| Jun 30, 2019 | 517.26 Mn |
| Mar 31, 2019 | 535.71 Mn |
| Dec 31, 2017 | 471.32 Mn |
| Jun 30, 2017 | 343.57 Mn |